Skip Navigation

2010 NIAID Year in Review

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

NIAID Funding for Selected Pathogens, Diseases, and Conditions: FY 2010

How NIAID Reports Expenditures

NIAID reports how appropriated funds are spent in different categories and classifications, including by pathogen (disease-causing organism), specific disease or condition, and research area. The table below represents funding levels for areas of interest to NIAID stakeholders. These areas do not represent the entire NIAID research portfolio. Funding for these areas can overlap and does not add up to the total NIAID budget. For example, funding for West Nile virus is represented in several areas, including vector-borne diseases, tropical medicine, and infectious diseases.

How NIAID Categorizes its Research

  • NIH Research, Condition, and Disease Categories (RCDC) – In response to the NIH Reform Act of 2006 (Public Law No. 109-482), NIH developed a consistent and transparent system to describe how NIH categorizes its research. RCDC reflects NIH funding levels in 229 research, condition, and disease categories.
  • Funding for NIAID research areas not reported through the RCDC process are coded and reported using the process in place before RCDC was implemented in FY 2008.

NIAID Funding for Selected Pathogens, Diseases, and Conditions – FY 2010

Pathogen, Disease, or Condition Dollars (in Thousands) Pathogen, Disease, or Condition Dollars (in Thousands)
Allergy $ 99,665 Leishmaniasis 1 $ 18,735
Allergic Rhinitis 1 1,743 Lupus 1 50,242
Food Allergy 19,039 Lyme Disease 1 19,701
Anaphylaxis 3,560 Malaria 1 105,926
Anthrax 1 101,154 Multiple Sclerosis 1 32,758
Arthritis 1 40,282 Parasitic Diseases 258,429
Asthma 1 70,985 Pandemic Influenza 282,946
Autoimmune Disease 184,500 Pediatric (Research) 1 272,072
Cholera 19,846 Pediatric AIDS 64,782
Dengue Virus 44,352 Pneumonia and Influenza 1 326,789
Diabetes 1 27,244 Primary Immune Deficiency Diseases 30,668
Diarrheal Diseases 165,779 Respiratory Diseases, Infectious 388,273
Digestive Diseases 1 318,728 Sexually Transmitted Diseases/Herpes 1 105,973
Ebola 58,619 Smallpox 1 88,387
Emerging Infectious Diseases 1 1,642,717 Staphylococcus aureus 65,772
Fungal Diseases 58,002 Methicillin-Resistant S. aureus 20,270
Hepatitis 1 79,298 Tropical Medicine 2 489,973
HIV/AIDS 1,577,322 Tuberculosis 1 137,728
Infectious Diseases, including HIV/AIDS 1 2,520,489 Vector-Borne Diseases 1 347,051
Inflammatory Bowel Disease 17,192 West Nile Virus 1 41,406
Other Research Dollars (in Thousands) Other Research Dollars (in Thousands)
Antimicrobial Resistance 1 268,708 Immune Tolerance 129,356
Biodefense 1,679,215 Prevention 1 1,463,751
Antibiotics/Antivirals 341,238 Radiological/Nuclear Research 3 47,572
Basic Research 850,576 Stem Cell Research 1 37,171
Diagnostic 85,719 Topical Microbicides 1 47,700
Vaccines 401,682 Transplantation 1 110,360
Chemical Countermeasures Research 3 49,135 Vaccine Development 1 1,303,072
Comparative Effectiveness Research 1 66,387 HPV and/or Cervical Cancer Vaccines 1 5,090
Food Safety 1 207,853 Vaccine-Related (AIDS) 1 467,155

Excludes Recovery Act funds
1 Represents topics and funding levels reported using the NIH RCDC process
2 Includes neglected tropical diseases
3 NIAID coordinates/manages these programs on behalf of NIH.

Last Updated November 17, 2011

Last Reviewed June 22, 2011